Feb 27, 2025 · Oncotype DX is the most common tumor profiling test used in the U.S. and the only one used in breast cancer staging. Other tumor profiling tests, such as MammaPrint ®, are available. Oncotype DX tests a sample of the tumor (removed during a biopsy or surgery) for a group of 21 genes.

Feb 13, 2024 · WebMD explains how the Oncotype DX test helps doctors predict if breast cancer will return and assists in determining the proper cancer treatment.

Jun 22, 2023 · What is the Oncotype DX test? The Oncotype DX is a test that looks at genes in breast cancer tissue. It may predict: Breast cancer prognosis (prog-NO-sis). Prognosis is the chance of the cancer coming back. If cancer comes back, it’s called recurrence (ree-KER-ents).

Dec 29, 2023 · OncoLink, the Web's first cancer resource,provides comprehensive information on coping with cancer, cancer treatments, cancer research advances, continuing medical education, cancer prevention, and clinical trials

Learn how the Oncotype DX tests can help you and your doctor decide on treatments after surgery for early-stage, estrogen receptor-positive breast cancer or DCIS.

Apr 11, 2020 · Postmenopausal women with early-stage, hormone receptor-positive, HER2-negative breast cancer and have an Oncotype test recurrence score of 0 to 25 do not benefit from treatment with chemotherapy according to the results from the RxPONDER clinical trial updated at the 2021 San Antonio Breast Cancer Symposium.

Let’s break down what an oncotype score is. Think of it as a personalized genetic test for your tumor—it looks at 21 specific genes within your cancer cells to predict how likely the cancer is to come back and whether chemotherapy would be beneficial in lowering that risk.

Mar 8, 2024 · Oncotype DX® testing is used if you meet these criteria: You have invasive breast cancer. It is used in women with invasive breast cancer but is being studied in men with breast cancer. The stage of your cancer is I, II, or IIIA. Your lymph nodes can be negative or you can have 1-3 positive nodes.

Jul 28, 2021 · Oncotype DX tests help doctors predict the future activity of cancer by analyzing genes in samples of breast, prostate, or colon cancer cells. The test results can help determine the risk of...

Patients are eligible for the Oncotype DX test if they are: And the cancer is: the Oncotype DX Breast DCIS Score® test. Read the groundbreaking results.